Simplexa Flu AlB & RSV Direct Assay Kits, intended for use as an aid in the differential diagnosi...

FDA Device Recall #Z-1144-2014 — Class II — February 4, 2014

Recall Summary

Recall Number Z-1144-2014
Classification Class II — Moderate risk
Date Initiated February 4, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Focus Diagnostics Inc
Location Cypress, CA
Product Type Devices
Quantity 2,175 kits

Product Description

Simplexa Flu AlB & RSV Direct Assay Kits, intended for use as an aid in the differential diagnosis of influenza A, influenza B, and RSV viral infections in humans and is not intended to detect influenza C. Model Number MOL2650.

Reason for Recall

Focus Diagnostics initiated the recall of the certain Simplexa Flu AlB & RSV Direct assay kits due to the potential of false positive Flu A, Flu B and RSV signals.

Distribution Pattern

Worldwide Distribution: US (nationwide) and to countries of:Canada, Sweden, Belgium, Spain, Portugal, Slovenia, and Israel.

Lot / Code Information

Model Number MOL2650. Lot Numbers: 24493, 24495, 24535, 24536, 24591, 24603, 24605, 24732, 24773, 24788, 24797, 24807.

Other Recalls from Focus Diagnostics Inc

Recall # Classification Product Date
Z-1686-2017 Class II Legionella IFA Substrate Slide (IF0951) intende... Feb 15, 2017
Z-1685-2017 Class II Legionella IFA (IF0950) intended for qualitativ... Feb 15, 2017
Z-1274-2016 Class I Simplexa Group A Strep Direct (MOL2850) with Di... Feb 10, 2016
Z-1272-2016 Class I Simplexa HSV 1&2 Direct (MOL2150) with Direct A... Feb 10, 2016
Z-1273-2016 Class II Simplexa Flu A/B & RSV Direct (MOL2650) with Di... Feb 10, 2016

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.